Position history for Brevan Howard Capital Management LP's holdings in REGENERON PHARMACEUTICALS
Brevan Howard Capital Management LP holds 19,985 shares of REGN (REGENERON PHARMACEUTICALS), worth $15.4M as of 2025-Q4. The position was increased (++281.4% shares). REGN represents 0.2% of Brevan Howard Capital Management LP's portfolio.
Current Value
$15.4M
Current Shares
19,985
Total Value Change
+$15.4M
Total Shares Change
+19,985
Increased |
| 19,985 |
+281.4% |
| $15.4M |
| 0.2% |
| $773.94 |
54 |
| 2025-Q3 | Decreased | 5,240 | -21.6% | $2.9M | 0.0% | $560.05 | 0 |
| 2025-Q2 | Decreased | 6,682 | -8.9% | $3.5M | 0.0% | $519.56 | 0 |
| 2025-Q1 | Decreased | 7,339 | -4.6% | $4.7M | 0.0% | $634.66 | 0 |
| 2024-Q4 | Increased | 7,690 | +141.5% | $5.5M | 0.0% | $698.71 | 44 |
| 2024-Q3 | New | 3,184 | - | $3.3M | 0.0% | $1,036.94 | 37 |
| 2024-Q2 | Exited | 0 | -100.0% | $0 | 0.0% | $1,045.23 | 0 |